Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
ELAN Stock Chart & Stats
$21.42
-$0.30(-2.54%)
At close: 4:00 PM EST
$21.42
-$0.30(-2.54%)
Day’s Range― - ―
52-Week Range$8.02 - $21.76
Previous CloseN/A
Volume2.53M
Average Volume (3M)5.43M
Market Cap
$10.19B
Enterprise Value$10.81B
Total Cash (Recent Filing)$539.00M
Total Debt (Recent Filing)$4.21B
Price to Earnings (P/E)23.5
Beta1.39
Next Earnings
Nov 05, 2025EPS Estimate
0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding496,813,700
10 Day Avg. Volume4,917,614
30 Day Avg. Volume5,431,689
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue2.41
Enterprise Value/Gross Profit5.61
Enterprise Value/Ebitda7.08
Forecast
1Y Price Target
$20.57Price Target Upside-3.97% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Innovation And Product LaunchesElanco's 2025 performance continues to outpace expectations, highlighted by another quarterly beat and raise with strength across the US & international pet health & farm animal businesses.
Market ShareCredelio Quattro's market share increased from 10% in Q1 to 14% at the end of Q2, and is expected to continue rising, contributing significantly to ELAN's revenues.
Revenue GrowthThe launch of Credelio Quattro is progressing well ahead of expectations with the product gaining traction in parts of the market and starting to become a meaningful contributor to revenues.
Bears Say
Competitive LandscapeThe implied 4Q guidance appears conservative to account for potential changes to the competitive landscape, at this juncture, but does imply a deceleration in revenue growth.
Label ConcernsThe black box remains on the label and still touches on safety concerns around vaccinations.
Elanco Animal Health News
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $8.02 and its highest was $21.76 in the past 12 months.
What is Elanco Animal Health’s market cap?
Elanco Animal Health’s market cap is $10.19B.
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is Nov 05, 2025 which is in 18 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on Aug 07, 2025. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.199 by $0.061.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Overvalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is 0.13.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 496,813,700 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.26 in its last earnings report, beating expectations of $0.199. Following the earnings report the stock price went up 18.136%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Currently, no hedge funds are holding shares in ELAN
Elanco Animal Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.57 (-3.97% Downside)
$20.57 (-3.97% Downside)
Blogger Sentiment
Neutral
ELAN Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 5.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.3%
Last 30 Days ▲ 33.8%
Last 30 Days ▲ 33.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.95%
12-Months-Change
Fundamentals
Return on Equity
6.83%
Trailing 12-Months
Asset Growth
-0.16%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health (ELAN) is a global leader in animal health, dedicated to advancing the health and well-being of pets and livestock. The company operates in two primary sectors: companion animals and food animals, providing a range of innovative products, including vaccines, parasiticides, antibiotics, and nutritional supplements. Elanco's mission is to enhance animal health through science-based solutions, ensuring better lives for animals and the people who care for them.
ELAN Company Deck
ELAN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant growth in organic revenue and innovation, supported by a robust Farm Animal segment and improved leverage ratios. However, the impact of tariffs and increased operating expenses, along with a decline in gross margin, presented challenges. The positive aspects of the call, including record growth and innovation success, outweigh the lowlights.View all ELAN earnings summariesELAN Stock 12 Month Forecast
Average Price Target
$20.57
▼(-3.97% Downside)
Technical Analysis
Dr Reddy's Laboratories
―
Viatris
―
Teva Pharmaceutical
―
Zoetis
―
Phibro Animal Health
―
Ownership Overview
0.97% Insiders
52.56% Mutual Funds
0.83% Other Institutional Investors
26.18% Public Companies and
Individual Investors